230 related articles for article (PubMed ID: 17151148)
1. Gaining: pediatric patients and use of atypical antipsychotics.
Towbin KE
Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
[No Abstract] [Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
4. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
5. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
[No Abstract] [Full Text] [Related]
6. Considering metformin in cardiometabolic protection in psychosis.
Curtis J; Newall H; Myles N; Shiers D; Samaras K
Acta Psychiatr Scand; 2012 Oct; 126(4):302-3. PubMed ID: 22804349
[No Abstract] [Full Text] [Related]
7. Metabolic syndrome and mental illness. Weight gain and other unhealthy attributes increase risk of diabetes and heart disease.
Harv Ment Health Lett; 2011 Aug; 28(2):5. PubMed ID: 21980633
[No Abstract] [Full Text] [Related]
8. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
9. Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs.
Andrade C
J Clin Psychiatry; 2016 Oct; 77(10):1362-1364. PubMed ID: 27788311
[TBL] [Abstract][Full Text] [Related]
10. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
[TBL] [Abstract][Full Text] [Related]
12. [Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics].
Gorobets LN
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):52-6. PubMed ID: 18833173
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of treatment with atypical antipsychotics.
Kane JM; Barrett EJ; Casey DE; Correll CU; Gelenberg AJ; Klein S; Newcomer JW
J Clin Psychiatry; 2004 Nov; 65(11):1447-55. PubMed ID: 15554755
[No Abstract] [Full Text] [Related]
14. Management of weight gain associated with antipsychotics.
Birt J
Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
[TBL] [Abstract][Full Text] [Related]
15. A program for managing weight gain associated with atypical antipsychotics.
Vreeland B; Minsky S; Menza M; Rigassio Radler D; Roemheld-Hamm B; Stern R
Psychiatr Serv; 2003 Aug; 54(8):1155-7. PubMed ID: 12883145
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-associated weight gain and clinical outcome parameters.
Blin O; Micallef J
J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
[TBL] [Abstract][Full Text] [Related]
17. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.
Ehret M; Goethe J; Lanosa M; Coleman CI
J Clin Psychiatry; 2010 Oct; 71(10):1286-92. PubMed ID: 20441727
[TBL] [Abstract][Full Text] [Related]
18. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of metformin to limit weight-gain with atypical antipsychotics.
Lee YJ; Jeong JH
J Clin Pharm Ther; 2011 Oct; 36(5):537-45. PubMed ID: 21418264
[TBL] [Abstract][Full Text] [Related]
20. Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues.
Andrade C
J Clin Psychiatry; 2016 Nov; 77(11):e1491-e1494. PubMed ID: 28076676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
